Effects of long-term pioglitazone treatment on peripheral and central markers of aging.
about
Current Research Therapeutic Strategies for Alzheimer's Disease TreatmentDeep sleep and parietal cortex gene expression changes are related to cognitive deficits with age.Age-related impairment in insulin release: the essential role of β(2)-adrenergic receptor.Hippocampal CA1 transcriptional profile of sleep deprivation: relation to aging and stress.Vitamin D prevents cognitive decline and enhances hippocampal synaptic function in aging rats.Low-level laser therapy improves the inflammatory profile of rats with heart failure.Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's diseaseIntranasal Insulin Improves Age-Related Cognitive Deficits and Reverses Electrophysiological Correlates of Brain AgingPioglitazone acutely reduces energy metabolism and insulin secretion in ratsHippocampal calcium dysregulation at the nexus of diabetes and brain aging.Latent mitochondrial DNA deletion mutations drive muscle fiber loss at old age.Calcium's role as nuanced modulator of cellular physiology in the brain.CA1 pyramidal cells have diverse biophysical properties, affected by development, experience, and agingEffect of high-fat diet on metabolic indices, cognition, and neuronal physiology in aging F344 rats.Reno-protection of G004, a novel anti-diabetic sulfonylurea in db/db mice.Expression of a Constitutively Active Human Insulin Receptor in Hippocampal Neurons Does Not Alter VGCC Currents.Pioglitazone, a PPAR-γ Activator, Stimulates BK but Suppresses IK in Hippocampal Neurons
P2860
Q26765530-79027798-7B15-49BF-AC2B-FAC1CF47EEAEQ33869293-E08E3FC1-5B80-46B5-B3C8-CD8040E546B6Q34252924-3C811F2C-3BD7-4453-9CEF-D410F4678322Q34335942-2B452C08-0211-450D-A3A6-DFD232B81E6DQ34383938-E25713DD-D30D-49A2-B80F-DE3D617BA808Q34398672-E3D0ADB8-1BDC-4AB7-8D39-C1D767D94BF8Q36044265-2E0EBEEA-F581-4EDB-8440-FE3E2408796CQ36444567-B6C831EC-C332-4692-9576-8B9C8A936A84Q36867430-C25DD0CF-D3CA-41A2-905D-A5BD8513FD8BQ37337291-760C7734-3BD8-431F-B946-72B89359E71AQ37422383-F9AA1002-C5A5-4821-878E-45AB9F960E69Q38935052-94505B53-2276-460A-84F9-328FA9788AA1Q41694511-F086A2F3-7B27-44CC-A21D-A20ACE07FD1DQ41880535-FAC3003C-FBF0-436F-A318-6396358DC247Q51303502-A2F5532C-4E08-42E3-9109-602000C00EC9Q51735696-C27C332E-35A0-4129-A96D-FED82CBDA0FDQ58694208-B3A5B0F3-C444-4D95-B3C3-1F4DFE749F1A
P2860
Effects of long-term pioglitazone treatment on peripheral and central markers of aging.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Effects of long-term pioglitazone treatment on peripheral and central markers of aging.
@ast
Effects of long-term pioglitazone treatment on peripheral and central markers of aging.
@en
type
label
Effects of long-term pioglitazone treatment on peripheral and central markers of aging.
@ast
Effects of long-term pioglitazone treatment on peripheral and central markers of aging.
@en
prefLabel
Effects of long-term pioglitazone treatment on peripheral and central markers of aging.
@ast
Effects of long-term pioglitazone treatment on peripheral and central markers of aging.
@en
P2093
P2860
P1433
P1476
Effects of long-term pioglitazone treatment on peripheral and central markers of aging.
@en
P2093
Don A Cohen
Eric M Blalock
James L Searcy
Jelena Popovic
Jeremiah T Phelps
John C Gant
Katie L Anderson
Kuey-Chu Chen
Margarita G Avdiushko
Nada M Porter
P2860
P304
P356
10.1371/JOURNAL.PONE.0010405
P407
P577
2010-04-29T00:00:00Z